Do mucosal mast cells contribute to the immediate asthma response?

Area of Science:

• Immunology
• Respiratory Medicine
• Cell Biology

Background:

• Two mast cell types, connective tissue mast cells (CTMCs) and mucosal mast cells (MMCs), exist in rat trachea.
• Previous research indicated CTMCs mediate tracheal contraction via 5-hydroxytryptamine (5-HT) release.

Purpose of the Study:

• To investigate the role of MMCs in rat tracheal contraction.
• To utilize mast cell-deficient (Ws/Ws) rats and congenic (+/+) rats to differentiate mast cell functions.

Main Methods:

• Rats were sensitized with ovalbumin and challenged.
• Compound 48/80 was used to deplete CTMCs, allowing MMCs to remain.
• Tracheal contractions were measured, and mediator levels (histamine, 5-HT, leukotrienes) were assessed.
• Pharmacological agents (ketanserin, ONO-1078) were used to identify mediators involved.

Main Results:

• Compound 48/80 effectively degranulated CTMCs while preserving MMCs, significantly reducing histamine levels.
• Ovalbumin challenge induced tracheal contraction in sensitized control rats but not in Ws/Ws or compound 48/80-treated rats.
• Contraction was inhibited by ketanserin (a 5-HT antagonist) but not by ONO-1078 (a leukotriene antagonist), indicating 5-HT mediation.

Conclusions:

• MMCs play a minimal role in 5-HT-mediated tracheal contraction.
• The findings suggest MMCs may have alternative functions in airway immunologic responses.
• Ws/Ws rats and congenic littermates serve as a robust model for investigating mast cell roles in airway immunity.